enow.com Web Search

  1. Ad

    related to: gastroparesis treatments 2023

Search results

  1. Results from the WOW.Com Content Network
  2. Gastroparesis: The causes, symptoms, and treatments for this ...

    www.aol.com/gastroparesis-causes-symptoms...

    Gastroparesis and anorexia nervosa are two distinct illnesses, however, there is evidence of gastroparesis and gastrointestinal motility issues resulting from anorexia nervosa. Researchers suspect ...

  3. Gastroparesis - Wikipedia

    en.wikipedia.org/wiki/Gastroparesis

    Gastroparesis (gastro- from Ancient Greek γαστήρ – gaster, "stomach"; and -paresis, πάρεσις – "partial paralysis") is a medical disorder of ineffective neuromuscular contractions (peristalsis) of the stomach, resulting in food and liquid remaining in the stomach for a prolonged period of time.

  4. Ozempic, Wegovy Users More Likely to Develop 'Stomach ... - AOL

    www.aol.com/lifestyle/ozempic-wegovy-users-more...

    New research presented this week highlights a link between drugs like Ozempic and a condition known as gastroparesis, so-called stomach paralysis. ... and Wegovy in October 2023. ... side effects ...

  5. Velusetrag - Wikipedia

    en.wikipedia.org/wiki/Velusetrag

    Velusetrag (INN, [1] USAN; previously known as TD-5108) is an experimental drug candidate for the treatment of gastric neuromuscular disorders including gastroparesis, and lower gastrointestinal motility disorders including chronic idiopathic constipation and irritable bowel syndrome. [2]

  6. Deudomperidone - Wikipedia

    en.wikipedia.org/wiki/Deudomperidone

    Deudomperidone (developmental code name CIN-102; also known as deuterated domperidone) is a dopamine antagonist medication which is under development in the United States for the treatment of gastroparesis. [1] [2] [3] It acts as a selective dopamine D 2 and D 3 receptor antagonist and has peripheral selectivity.

  7. Relamorelin - Wikipedia

    en.wikipedia.org/wiki/Relamorelin

    Relamorelin (INN, USAN) (developmental code names RM-131, BIM-28131, BIM-28163) is a synthetic peptide, centrally penetrant, selective agonist of the ghrelin/growth hormone secretagogue receptor (GHSR) which is under development by Allergan pharmaceuticals for the treatment of diabetic gastroparesis, chronic idiopathic constipation, and anorexia nervosa.

  8. Prokinetic agent - Wikipedia

    en.wikipedia.org/wiki/Prokinetic_agent

    They are used to treat certain gastrointestinal symptoms, including abdominal discomfort, bloating, constipation, heart burn, nausea, and vomiting; and certain gastrointestinal disorders, including irritable bowel syndrome, gastritis, [2] gastroparesis, and functional dyspepsia.

  9. Baby Has $5 Million Surgery to Remove Left Side of Brain at ...

    www.aol.com/baby-5-million-surgery-remove...

    “They told us as soon as they gave us the diagnosis that pretty much the only course of treatment would be to get a hemispherectomy, which is a surgery to remove the left side of the brain ...

  1. Ad

    related to: gastroparesis treatments 2023